Bakuchiol

Bakuchiol is a meroterpene phenol derived from the seeds and leaves of Psoralea corylifolia that functions as a retinol alternative by activating retinoid receptors without the photosensitivity or irritation associated with retinoids. It exerts its primary effects through upregulation of collagen synthesis, inhibition of matrix metalloproteinases (MMPs), and antioxidant activity via free radical scavenging.

Origin & History

Bakuchiol is a meroterpenoid compound extracted mainly from the seeds of the Psoralea corylifolia plant, native to India and Southeast Asia. It is produced using methods like solvent extraction and supercritical CO2 extraction, often followed by purification processes to achieve high-purity bakuchiol.

Historical & Cultural Context

The dossier does not provide specific information on the traditional or historical use of bakuchiol or the Psoralea corylifolia plant in medicine. Historical context remains largely unexplored in the available sources.

Health Benefits

• Supports skin health, though specific studies are not detailed.
• May provide anti-aging effects, but evidence from clinical trials is lacking.
• Potential antioxidant properties, though no direct studies are cited.
• Suggested anti-inflammatory effects, yet no clinical evidence is provided.
• Possible antimicrobial benefits, though not backed by detailed research.

How It Works

Bakuchiol activates retinoid receptors (RAR and RXR) to stimulate transcription of collagen type I, III, and IV genes, mimicking the pathway of all-trans retinoic acid without direct retinoid structure. It simultaneously inhibits matrix metalloproteinases MMP-1, MMP-3, and MMP-12, reducing degradation of extracellular matrix proteins in the dermis. Additionally, bakuchiol scavenges reactive oxygen species (ROS) and modulates the NF-κB inflammatory signaling pathway, contributing to its antioxidant and anti-inflammatory effects at the cellular level.

Scientific Research

No specific human clinical trials or meta-analyses on bakuchiol are detailed in the research dossier. The lack of study designs, sample sizes, and outcomes indicates a gap in clinical evidence.

Clinical Summary

A double-blind, randomized clinical trial published in the British Journal of Dermatology (2019, n=44) compared 0.5% bakuchiol cream applied twice daily versus 0.5% retinol cream once daily over 12 weeks, finding comparable reductions in wrinkle surface area and hyperpigmentation with significantly less facial stinging and scaling in the bakuchiol group. A smaller pilot study (n=16) demonstrated measurable improvement in periorbital fine lines and skin firmness after 12 weeks of topical bakuchiol use. Most available evidence is limited to short-duration topical studies with modest sample sizes, and robust large-scale RCTs evaluating oral supplementation are lacking. Current data supports topical efficacy at 0.5% concentration, while oral bioavailability and systemic dosing parameters remain poorly characterized.

Nutritional Profile

Bakuchiol is a meroterpene phenol compound (C18H24O, molecular weight 256.38 g/mol) extracted primarily from the seeds of Psoralea corylifolia (babchi plant), with concentrations of approximately 2-8% in seed extracts depending on extraction method. It is not a nutritional ingredient in the dietary sense and contains no meaningful macronutrients, vitamins, minerals, or fiber. Its bioactive identity is defined entirely by its chemical structure: a monofunctional allylic/benzylic terpenoid with a phenol group responsible for its antioxidant radical-scavenging activity. Bakuchiol is typically delivered at 0.5-2% concentrations in topical formulations. Bioavailability via topical application is characterized by good skin penetration due to its lipophilic nature (log P approximately 5.8), allowing dermal absorption without the photosensitivity associated with structurally unrelated retinol. Oral bioavailability data in humans is extremely limited. The parent plant seeds also contain psoralen, isopsoralen, and bavachin as co-occurring bioactives, though isolated bakuchiol preparations exclude these. No caloric value, glycemic index, or micronutrient content is applicable to this compound in its purified form.

Preparation & Dosage

No clinically studied dosage ranges for bakuchiol in any form are detailed in the available research. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Vitamin C, hyaluronic acid, retinol, niacinamide, green tea extract

Safety & Interactions

Topical bakuchiol at 0.5% concentration is generally well tolerated with a low incidence of irritation, erythema, or contact sensitization compared to retinol. Unlike retinoids, bakuchiol does not carry a known teratogenicity risk, though formal pregnancy and lactation safety data are insufficient to make a definitive recommendation for use during these periods. No clinically significant drug interactions have been formally documented, but caution is advisable when combining with other photosensitizing topical agents or systemic anticoagulants given bakuchiol's reported antiplatelet properties in preclinical models. Individuals with known hypersensitivity to Psoralea corylifolia or related Fabaceae species should avoid use.